Literature DB >> 16022076

A comparison of visual analogue and numerical rating scale formats for the Lung Cancer Symptom Scale (LCSS): does format affect patient ratings of symptoms and quality of life?

P J Hollen1, R J Gralla, M G Kris, S McCoy, G W Donaldson, C M Moinpour.   

Abstract

PROBLEM AND
PURPOSE: The Lung Cancer Symptom Scale (LCSS), a site-specific health-related quality of life measure for patients with lung cancer, was originally developed using a Visual Analogue Scale (VAS) format. However, the VAS format is not readily compatible with data management and software programs using scanning. The primary aim of this study was to evaluate the convergence of ratings obtained with a Numerical Rating Scale (NRS), with an 11-pt response category format, to those obtained with a VAS format. The intent was to determine the degree of agreement between two formats to generalize the existing psychometric properties for the original measure to the new presentation. DESIGN/
SETTING: This methodological study evaluated the feasibility, reliability, and validity of a NRS format for the LCSS. The study was conducted at two cancer centers in New York City. PATIENTS/PROCEDURES: Sixty-eight patients with non-small cell lung cancer (NSCLC) completed both versions of the LCSS along with demographic and feasibility questions on a single occasion. The VAS form was administered first, followed by the NRS form to prevent bias. The intraclass correlation coefficient (ICC), Lin's concordance correlation coefficient (CCC), and Bland-Altman plots were used to evaluate agreement and to characterize bias.
RESULTS: Cronbach's alpha for the NRS format total score was 0.89 for the 68 patients with NSCLC. Agreement was excellent, with both the ICC and CCC > or = 0.90 for the two summary scores (total score and average symptom burden index) for the LCSS. Only five of the nine individual items showed this level of strict agreement. An agreement criterion of > or = 0.80 (representing excellent) was observed for seven of the nine individual items (all but appetite loss and hemoptysis). Mean differences tended to be slightly lower for the VAS format compared to the NRS format (more so for the appetite and hemoptysis items), with evidence of scale shift for the same two items. The summary measures showed good concordance as measured by the ICC and CCC, but did display mean differences (VAS - NRS) of -2.7 and -3.1, respectively.
CONCLUSIONS: Overall, the NRS format for the LCSS suitable for scanning has good feasibility, reliability (internal consistency), and convergent validity. The complete set of concordance evaluation measures supports the reproducibility of VAS scores by NRS scores, particularly for the two summary scores.

Entities:  

Mesh:

Year:  2005        PMID: 16022076     DOI: 10.1007/s11136-004-0833-8

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  21 in total

1.  Estimating the generalized concordance correlation coefficient through variance components.

Authors:  Josep L Carrasco; Lluís Jover
Journal:  Biometrics       Date:  2003-12       Impact factor: 2.571

2.  Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation.

Authors:  R A Deyo; P Diehr; D L Patrick
Journal:  Control Clin Trials       Date:  1991-08

3.  A concordance correlation coefficient to evaluate reproducibility.

Authors:  L I Lin
Journal:  Biometrics       Date:  1989-03       Impact factor: 2.571

4.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

5.  Methodological issues in assessing reproducibility--a comparative study of various indices of reproducibility applied to repeat ELISA serologic tests for Lyme disease.

Authors:  M C Tammemagi; J W Frank; M Leblanc; H Artsob; D L Streiner
Journal:  J Clin Epidemiol       Date:  1995-09       Impact factor: 6.437

6.  Pain and its treatment in outpatients with metastatic cancer.

Authors:  C S Cleeland; R Gonin; A K Hatfield; J H Edmonson; R H Blum; J A Stewart; K J Pandya
Journal:  N Engl J Med       Date:  1994-03-03       Impact factor: 91.245

7.  Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale.

Authors:  P J Hollen; R J Gralla; M G Kris; C Cox; C P Belani; S M Grunberg; J Crawford; J A Neidhart
Journal:  Cancer       Date:  1994-04-15       Impact factor: 6.860

8.  Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer.

Authors:  J A Sloan; C L Loprinzi; S A Kuross; A W Miser; J R O'Fallon; M R Mahoney; I M Heid; M E Bretscher; N L Vaught
Journal:  J Clin Oncol       Date:  1998-11       Impact factor: 44.544

9.  Cancer pain intensity measurement: concurrent validity of three tools--finger dynamometer, pain intensity number scale, visual analogue scale.

Authors:  D Wilkie; N Lovejoy; M Dodd; M Tesler
Journal:  Hosp J       Date:  1990

10.  The validity of proxy-generated scores as measures of patient health status.

Authors:  M L Rothman; S C Hedrick; K A Bulcroft; D H Hickam; L Z Rubenstein
Journal:  Med Care       Date:  1991-02       Impact factor: 2.983

View more
  25 in total

1.  A Randomized Study of Electronic Diary versus Paper and Pencil Collection of Patient-Reported Outcomes in Patients with Non-Small Cell Lung Cancer.

Authors:  Alistair E Ring; Kerry A Cheong; Claire L Watkins; David Meddis; David Cella; Peter G Harper
Journal:  Patient       Date:  2008-04-01       Impact factor: 3.883

2.  Microwave ablation therapy for treating primary and secondary lung tumours: technical note.

Authors:  G Carrafiello; M Mangini; I De Bernardi; F Fontana; G Dionigi; S Cuffari; A Imperatori; D Laganà; C Fugazzola
Journal:  Radiol Med       Date:  2010-03-29       Impact factor: 3.469

3.  Measuring quality of life with fuzzy numbers: in the perspectives of reliability, validity, measurement invariance, and feasibility.

Authors:  Po-Yi Chen; Grace Yao
Journal:  Qual Life Res       Date:  2014-10-14       Impact factor: 4.147

4.  Distress before chemotherapy predicts delayed but not acute nausea.

Authors:  Sara C Higgins; Guy H Montgomery; Dana H Bovbjerg
Journal:  Support Care Cancer       Date:  2006-08-03       Impact factor: 3.603

5.  Lung cancer stigma: A concept with consequences for patients.

Authors:  Roma Maguire; Liane Lewis; Grigorios Kotronoulas; John McPhelim; Robert Milroy; Janine Cataldo
Journal:  Cancer Rep (Hoboken)       Date:  2019-06-24

6.  Can a computerized format replace a paper form in PRO and HRQL evaluation? Psychometric testing of the computer-assisted LCSS instrument (eLCSS-QL).

Authors:  Patricia J Hollen; Richard J Gralla; John A Stewart; Jacinta M Meharchand; Rafal Wierzbicki; Natasha Leighl
Journal:  Support Care Cancer       Date:  2012-06-10       Impact factor: 3.603

7.  A psychometric analysis of quality of life tools in lung cancer patients who smoke.

Authors:  Kristine K Browning; Amy K Ferketich; Gregory A Otterson; Nancy R Reynolds; Mary Ellen Wewers
Journal:  Lung Cancer       Date:  2009-01-31       Impact factor: 5.705

8.  The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties.

Authors:  Robert M Bennett; Ronald Friend; Kim D Jones; Rachel Ward; Bobby K Han; Rebecca L Ross
Journal:  Arthritis Res Ther       Date:  2009-08-10       Impact factor: 5.156

9.  How should we use the visual analogue scale (VAS) in rehabilitation outcomes? II: Visual analogue scales as ratio scales: an alternative to the view of Kersten et al.

Authors:  Donald D Price; Roland Staud; Michael E Robinson
Journal:  J Rehabil Med       Date:  2012-09       Impact factor: 2.912

10.  Memory for fatigue in chronic fatigue syndrome: relationships to fatigue variability, catastrophizing, and negative affect.

Authors:  Stephanie J Sohl; Fred Friedberg
Journal:  Behav Med       Date:  2008       Impact factor: 3.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.